468 related articles for article (PubMed ID: 30169982)
1. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
[TBL] [Abstract][Full Text] [Related]
2. Chitosan based controlled release drug delivery of mycophenolate mofetil loaded in nanocarriers system: synthesis and
Zaman M; Iqbal A; Haider Rizvi SF; Hussain MA; Jamshaid T; Jamshaid M
Drug Dev Ind Pharm; 2021 Mar; 47(3):477-483. PubMed ID: 33621153
[No Abstract] [Full Text] [Related]
3. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
5. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Characterization of an Oral Norethindrone Sustained Release/Controlled Release Nanoparticles Formulation Based on Chitosan.
Altaani BM; Al-Nimry SS; Haddad RH; Abu-Dahab R
AAPS PharmSciTech; 2019 Jan; 20(2):54. PubMed ID: 30617756
[TBL] [Abstract][Full Text] [Related]
7. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
8. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs.
Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK
Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096
[TBL] [Abstract][Full Text] [Related]
9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
10. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.
Choonara YE; Pillay V; Ndesendo VM; du Toit LC; Kumar P; Khan RA; Murphy CS; Jarvis DL
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):243-54. PubMed ID: 21664111
[TBL] [Abstract][Full Text] [Related]
11. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
13. Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant.
Iqbal A; Zaman M; Wahab Amjad M; Adnan S; Abdul Ghafoor Raja M; Haider Rizvi SF; Mustafa MW; Farooq U; Abbas G; Shah S
Int J Nanomedicine; 2020; 15():5603-5612. PubMed ID: 32848390
[TBL] [Abstract][Full Text] [Related]
14. Development of a non-toxic and non-denaturing formulation process for encapsulation of SDF-1α into PLGA/PEG-PLGA nanoparticles to achieve sustained release.
Haji Mansor M; Najberg M; Contini A; Alvarez-Lorenzo C; Garcion E; Jérôme C; Boury F
Eur J Pharm Biopharm; 2018 Apr; 125():38-50. PubMed ID: 29325770
[TBL] [Abstract][Full Text] [Related]
15. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
Abouelmagd SA; Ku YJ; Yeo Y
J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
20. PLA/PLGA nanoparticles for sustained release of docetaxel.
Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
